PH-ILD: Optimizing Screening Strategies for Accurate Diagnosis and Timely Intervention

October 10, 2023 from 5:15 am 6:45 am HST

This activity is supported by an educational grant from United Therapeutics Corporation.

Program Description

To manage pulmonary hypertension due to interstitial lung disease (PH-ILD) effectively, it’s essential to prioritize routine screening, timely diagnosis, and awareness of the latest evidence supporting new treatment options. During this CME breakfast symposium Drs. Steven Nathan, Jean M. Elwing, and Oksana A. Shlobin will review the key characteristics of the disease and provide evidence-based strategies for screening, identifying, and treating PH-ILD.

This symposium will also feature RAPID-FIRE ROUNDTABLE, an engaging fast-paced exchange of their clinical expert perspectives!

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.


Oksana A. Shlobin, MD, FCCP
Inova Fairfax Hospital
Pulmonary Hypertension Program
Medical Director
Inova Fairfax Hospital
Advanced Lung Disease and Transplant Program
Director of Education
University of Virginia School of Medicine
Associate Professor of Clinical Education
Fairfax, VA

Steven D. Nathan, MD, FCCP
Inova Fairfax Hospital
Advanced Lung Disease and Transplant Program
Medical Director
Falls Church, VA

Jean M. Elwing, MD, FACP, FCCP
University of Cincinnati
Director, Pulmonary Hypertension Program Pulmonary Hypertension Association Certified Center (PHCCC) Pulmonary, Critical Care and Sleep Medicine
Professor of Medicine
Cincinnati, OH